[{"title": "TBK1 p. Y153Qfs* 9 variant may be associated with young-onset, rapidly progressive amyotrophic lateral sclerosis through a haploinsufficiency mechanism", "link": "https://journals.lww.com/jcma/_layouts/15/oaks.journals/downloadpdf.aspx%3Fan%3D02118582-990000000-00423", "details": "SY Fang, PC Tsai, KY Jih, FC Hsu, YC Liao, CC Yang\u2026 - Journal of the Chinese Medical \u2026", "abstract": "Background: TBK1 variants have been implicated in the pathogenesis of amyotrophic lateral sclerosis (ALS) and frontotemporal dementia spectrum disorder. The current study elucidated the clinical and molecular genetic features of a novel \u2026"}, {"title": "Assessing Dimensions of Thought Disorder with Large Language Models: The Tradeoff of Accuracy and Consistency", "link": "https://www.sciencedirect.com/science/article/pii/S0165178124004049", "details": "SL Pugh, C Chandler, AS Cohen, C Diaz-Asper\u2026 - Psychiatry Research, 2024", "abstract": "Abstract Natural Language Processing (NLP) methods have shown promise for the assessment of formal thought disorder, a hallmark feature of schizophrenia in which disturbances to the structure, organization, or coherence of thought can manifest as \u2026"}, {"title": "Safety, tolerability, and pharmacokinetics of antisense oligonucleotide BIIB078 in adults with C9orf72-associated amyotrophic lateral sclerosis: a phase 1, randomised \u2026", "link": "https://www.thelancet.com/article/S1474-4422\\(24\\)00216-3/abstract", "details": "LH van den Berg, JD Rothstein, PJ Shaw, S Babu\u2026 - The Lancet Neurology, 2024", "abstract": "Background Hexanucleotide repeat expansion of C9orf72 is a common genetic cause of amyotrophic lateral sclerosis (ALS). No C9orf72-targeted treatments are available. BIIB078 is an investigational antisense oligonucleotide targeting C9orf72 \u2026"}, {"title": "CALLM: Enhancing Clinical Interview Analysis through Data Augmentation with Large Language Models", "link": "https://ieeexplore.ieee.org/abstract/document/10614318/", "details": "Y Wu, K Mao, Y Zhang, J Chen - IEEE Journal of Biomedical and Health Informatics, 2024", "abstract": "The global prevalence of mental health disorders is increasing, leading to a significant economic burden estimated in trillions of dollars. In automated mental health diagnosis, the scarcity and imbalance of clinical data pose considerable \u2026"}, {"title": "Increase of HCN current in SOD1-associated amyotrophic lateral sclerosis", "link": "https://academic.oup.com/brain/advance-article-abstract/doi/10.1093/brain/awae248/7725654", "details": "HJ Lai, YC Kuo, CH Ting, CC Yang, CH Kao, YC Tsai\u2026 - Brain, 2024", "abstract": "The clinical manifestations of sporadic amyotrophic lateral sclerosis (ALS) vary widely. However, the current classification of ALS is mainly based on clinical presentations, while the roles of electrophysiological and biomedical biomarkers \u2026"}, {"title": "Changes in Cerebrospinal Fluid Concentrations of Selenium Species Induced by Tofersen Administration in Subjects with Amyotrophic Lateral Sclerosis Carrying \u2026", "link": "https://link.springer.com/article/10.1007/s12011-024-04311-4", "details": "M Vinceti, T Urbano, T Filippini, R Bedin, C Simonini\u2026 - Biological Trace Element \u2026, 2024", "abstract": "Amyotrophic lateral sclerosis (ALS) is a fatal neurodegenerative disease affecting the brain and spinal cord motor neurons. On 25 April 2023, the drug tofersen, an antisense oligonucleotide, received the US Food and Drug Administration approval \u2026"}, {"title": "Tofersen decreases neurofilament levels supporting the pathogenesis of the SOD1 p. D91A variant in amyotrophic lateral sclerosis patients", "link": "https://www.nature.com/articles/s43856-024-00573-0", "details": "JH Weishaupt, P K\u00f6rtv\u00e9lyessy, P Schumann\u2026 - Communications medicine, 2024", "abstract": "Background Since the antisense oligonucleotide tofersen has recently become available for the treatment of amyotrophic lateral sclerosis (ALS) caused by mutations in SOD1, determining the causality of the over 230 SOD1 variants has \u2026"}, {"title": "The burden of upper motor neuron involvement is correlated with the bilateral limb involvement interval in patients with amyotrophic lateral sclerosis: a retrospective \u2026", "link": "https://journals.lww.com/nrronline/fulltext/2025/05000/the_burden_of_upper_motor_neuron_involvement_is.32.aspx", "details": "J Wu, S Ye, X Liu, Y Xu, D Fan - Neural Regeneration Research, 2025", "abstract": "Amyotrophic lateral sclerosis is a rare neurodegenerative disease characterized by the involvement of both upper and lower motor neurons. Early bilateral limb involvement significantly affects patients' daily lives and may lead them to be \u2026"}, {"title": "Generation of Human-Induced Pluripotent Stem Cells from Peripheral Blood Mononuclear Cells of C9ORF72-Associated Amyotrophic Lateral Sclerosis Patients", "link": "https://link.springer.com/protocol/10.1007/978-1-0716-3995-5_12", "details": "K Andrysiak, J St\u0119pniewski, M Spaczy\u0144ska-Boczar\u2026 - Adult Stem Cells: Methods \u2026, 2024", "abstract": "Disease modeling of neuromuscular disorders, such as amyotrophic lateral sclerosis (ALS), is hindered by limited accessibility of affected cells. This problem can be overcome by generation of human induced pluripotent stem cells (hiPSC), which can \u2026"}]
